These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3371072)

  • 1. Thimerosal: an ophthalmic preservative which acts as a hapten to elicit specific antibodies and cell mediated immunity.
    Cai F; Backman HA; Baines MG
    Curr Eye Res; 1988 Apr; 7(4):341-51. PubMed ID: 3371072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The sensitizing capacity of merthiolate and its methyl analogue.
    Möller H; Trofast J
    J Biol Stand; 1979 Jul; 7(3):153-55. PubMed ID: 500735
    [No Abstract]   [Full Text] [Related]  

  • 3. Delayed hypersensitivity to thimerosal in contact lens solutions.
    Zeigen SR; Jacobs IH; Weinberger GI
    J Med Soc N J; 1981 May; 78(5):362-4. PubMed ID: 6945439
    [No Abstract]   [Full Text] [Related]  

  • 4. Delayed hypersensitivity to thimerosal in soft contact lens wearers.
    Wilson LA; McNatt J; Reitschel R
    Ophthalmology; 1981 Aug; 88(8):804-9. PubMed ID: 7322498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular hypersensitivity to thimerosal in rabbits.
    Baines MG; Cai F; Backman HA
    Invest Ophthalmol Vis Sci; 1991 Jul; 32(8):2259-65. PubMed ID: 2071338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allergic and toxic reactions of soft contact lens wearers.
    Mondino BJ; Salamon SM; Zaidman GW
    Surv Ophthalmol; 1982; 26(6):337-44. PubMed ID: 6810487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thimerosal-dependent antibody enhanced in the presence of LISS.
    Spencer GT; McDowell MA
    Vox Sang; 1985; 49(6):422-3. PubMed ID: 4090413
    [No Abstract]   [Full Text] [Related]  

  • 8. The adjuvant effect of tuberculin in experimental sensitization to merthiolate.
    Magnusson B; Möller H
    Arch Dermatol Res (1975); 1977 May; 258(3):235-9. PubMed ID: 583641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mercury-induced hypersensitivity rare after subcutaneous injection of vaccines].
    Taranger J
    Lakartidningen; 1990 Apr; 87(16):1345. PubMed ID: 2329881
    [No Abstract]   [Full Text] [Related]  

  • 10. Two further examples of IgG thimerosal-dependent antibodies and their serological characteristics.
    Valbonesi M; Vassallo F; Lercari G; Frisoni R; Carubia F; Russo E
    Ric Clin Lab; 1987; 17(1):47-51. PubMed ID: 3589402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thiomersal allergy and vaccination reactions.
    Cox NH; Forsyth A
    Contact Dermatitis; 1988 Apr; 18(4):229-33. PubMed ID: 3378430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thimerosal: a hidden allergen in ophthalmology.
    Tosti A; Tosti G
    Contact Dermatitis; 1988 May; 18(5):268-73. PubMed ID: 3416589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the ophthalmic preservative thimerosal on rabbit and human corneal endothelium.
    Van Horn DL; Edelhauser HF; Prodanovich G; Eiferman R; Pederson HF
    Invest Ophthalmol Vis Sci; 1977 Apr; 16(4):273-80. PubMed ID: 844986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photochemical linking of primary aromatic amines to carrier proteins to elicit antibody response against the amine haptens.
    Pandey RN; Davis LE; Anderson B; Hollenberg PF
    J Immunol Methods; 1986 Nov; 94(1-2):237-46. PubMed ID: 3782813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preservative-related problems in soft contact lens wearers.
    Wright P; Mackie I
    Trans Ophthalmol Soc U K (1962); 1982 Apr; 102 (Pt 1)():3-6. PubMed ID: 6963061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An assessment of thimerosal use in childhood vaccines.
    Ball LK; Ball R; Pratt RD
    Pediatrics; 2001 May; 107(5):1147-54. PubMed ID: 11331700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological specificity of delayed and immediate hypersensitivity reactions.
    BENACERRAF B; LEVINE BB
    J Exp Med; 1962 May; 115(5):1023-36. PubMed ID: 13867017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years.
    Thompson WW; Price C; Goodson B; Shay DK; Benson P; Hinrichsen VL; Lewis E; Eriksen E; Ray P; Marcy SM; Dunn J; Jackson LA; Lieu TA; Black S; Stewart G; Weintraub ES; Davis RL; DeStefano F;
    N Engl J Med; 2007 Sep; 357(13):1281-92. PubMed ID: 17898097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Letter: Thimerosal reaction and cell-mediated immunity.
    Hansson H; Möller H
    N Engl J Med; 1974 May; 290(21):1202. PubMed ID: 4824019
    [No Abstract]   [Full Text] [Related]  

  • 20. A review of Thimerosal (Merthiolate) and its ethylmercury breakdown product: specific historical considerations regarding safety and effectiveness.
    Geier DA; Sykes LK; Geier MR
    J Toxicol Environ Health B Crit Rev; 2007 Dec; 10(8):575-96. PubMed ID: 18049924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.